Exercise modulates the aortic renin-angiotensin system independently of estrogen therapy in ovariectomized hypertensive rats

Peptides

Volumn 87, Issue , 2017, Pages 41-49

  Endlich, Patrick W ^a,b   Claudio, Erick R G ^a   Lima, Leandro C F ^c   Ribeiro Júnior, Rogério F ^a   Peluso, Antonio A B ^c   Stefanon, Ivanita ^a   Bissoli, Nazaré S ^a   Lemos, Virginia S ^c   Santos, Robson A S dos ^c   Abreu, Glaucia R de ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Federal University of Valleys of Jequitinhonha and Mucuri   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Angiotensin II; Angiotensin (1 7); Estrogen therapy; SHR; Swimming; Vascular reactivity

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN[1-7]; ESTRADIOL BENZOATE; ANGIOTENSIN I; ANGIOTENSIN I (1-7); ESTRADIOL; ESTROGEN; PEPTIDE FRAGMENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA WALL; ARTICLE; BLOOD SAMPLING; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HYPERTENSION; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SWIMMING; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; VASODILATATION; ANIMAL; BLOOD; GENETICS; HUMAN; KINESIOTHERAPY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; AORTA; ESTRADIOL; ESTROGENS; EXERCISE THERAPY; HUMANS; HYPERTENSION; OVARIECTOMY; PEPTIDE FRAGMENTS; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, INBRED SHR; RENIN-ANGIOTENSIN SYSTEM;

EID: 84999219583     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2016.11.010     Document Type: Article

References (50)

1. [1] Wenger, N.K., Speroff, L., Packard, B., Cardiovascular health and disease in women. N. Engl. J. Med. 329 (1993), 247–256.
2. [2] Colditz, G.A., Willett, W.C., Stampfer, M.J., Rosner, B., Speizer, F.E., Hennekens, C.H., Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 316 (1987), 1105–1110.
3. [3] Burl, V.L., Welton, P., Roccella, E.J., Brown, C., Cutler, J.A., Higgins, M., Horan, M.J., Labarthe, D., Prevalence of hypertension in the US adult population results from the third national health and nutrition examination survey, 1988–1991. Hypertension 25 (1995), 305–313.
4. [4] Hong, M.K., Romm, P.A., Reagan, K., Green, C.E., Rackley, C.E., Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women. Am. J. Cardiol. 69 (1992), 176–178.
5. [5] Heckbert, S.R., Weiss, N.S., Koepsell, T.D., Lemaitre, R.N., Smith, N.L., Siscovick, D.S., Lin, D., Psaty, B.M., Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women. Arch. Intern. Med. 157 (1997), 1330–1336.
6. [6] Nogawa, N., Sumino, H., Ichikawa, S., Kumakura, H., Takayama, Y., Nakamura, T., Kanda, T., Mizunuma, H., Kurabayashi, M., Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women. Menopause 8 (2001), 210–215.
7. [7] Schunkert, H., Danser, A.H., Hense, H.W., Derkx, F.H., Kurzinger, S., Riegger, G.A., Effects of estrogen replacement therapy on the renin-angiotensin system in post-menopausal women. Circulation 95 (1997), 39–45.
8. [8] Hinojosa-Laborde, C., Craig, T., Zheng, W., Ji, H., Haywood, J.R., Sandberg, K., Ovariectomy augments hypertension in aging female Dahl salt-sensitive rats. Hypertension 44 (2004), 405–409.
9. [9] Nickenig, G., Baumer, A.T., Grohe, C., et al. Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97 (1998), 2197–2201.
10. [10] Wassmann, S., Baumer, A.T., Strehlow, K., et al. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103 (2001), 435–441.
11. [11] Dean, S.A., Tan, J., O'Brien, E.R., Leenen, F.H.H., 17β-Estradiol downregulates tissue angiotensin-converting enzyme and ANG II type 1 receptor in female rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (2005), R759–766.
12. 2 receptors in the rat. Regul. Pept. 124 (2005), 7–17.
13. [13] Stennett, A.K., Qiao, X., Falone, A., Koledova, V.V., Khalil, R.A., Increased vascular angiotensin type 2 receptor expression and NOS-mediated mechanisms of vascular relaxation in pregnant rats. Am. J. Heart Circ. Physiol. 296 (2009), H745–H755.
14. [14] Neves, L.A., Williams, A.F., Averill, D.B., Ferrario, C.M., Walkup, M.P., Bronishan, K.B., Pregnancy enhances the angiotensin (Ang)-(1-7) vasodilator response in mesenteric arteries and increases the renal concentration and urinary excretion of Ang-(1-7). Endocrinology 144 (2003), 3338–3343.
15. [15] Grobe, J.L., Katovich, M.J., Alterations in aortic vascular reactivity to angiotensin 1-7 in 17-beta-estradiol-treated female SD rats. Regul. Pept. 133 (2006), 62–67.
16. [16] Hsia, J., Langer, R.D., Manson, J.E., et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch. Intern. Med. 166:3 (2006), 357–365.
17. [17] Adamu, B., Sani, M.U., Abdu, A., Physical exercise and health: a review. Niger. J. Med. 15 (2006), 190–196.
18. [18] Asikainen, T.M., Kukkonen-Harjula, K., Miilunpalo, S., Exercise for health for early postmenopausal women: a systematic review of randomized controlled trials. Sports Med. 34 (2004), 753–778.
19. [19] Oliveira, V., Akamine, E.H., Carvalho, M.H., Michelini, L.C., Fortes, Z.B., Cunha, T.S., do Carmo Franco, M.I., Influence of aerobic training on the reduced vasoconstriction to angiotensin II in rats exposed to intrauterine growth restriction: possible role of oxidative stress and AT2 receptor of angiotensin II. PLoS One, 9(11), 2014, e113035.
20. [20] Adams, V., Linke, A., Kränkel, N., et al. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 111 (2005), 555–562.
21. [21] Rush, J.W.E., Aultman, C.D., Vascular biology of angiotensin and the impact of physical activity. Appl. Physiol. Nutr. Metab. 33 (2008), 162–172.
22. [22] Xu, X., Wan, W., Ji, L., Lao, S., Powers, A.S., Zhao, W., Erikson, J.M., Zhang, J.Q., Exercise training combined with angiotensin II receptor blockade limits post-infarct ventricular remodeling in rats. Cardiovasc. Res. 78 (2008), 523–532.
23. [23] Zamo, F.S., Barauna, V.G., Chiavegatto, S., Irigoyen, M.C., Oliveira, E.M., The renin-angiotensin system is modulated by swimming training depending on the age of spontaneously hypertensive rats. Life Sci. 89:3–4 (2011), 93–99.
24. [24] M.X. Zarrow, Experimental Endocrinology: a sourcebook of basic techniques. Academic Press (New York).
25. [25] Claudio, E.R.G., Endlich, P.W., Santos, R.L., et al. Effects of chronic swimming training and oestrogen therapy on coronary vascular reactivity and expression of antioxidant enzymes in ovariectomized rats. PLoS One, 8(6), 2013, e64806.
26. [26] Saengsirisuwan, V., Pongseeda, S., Prasannarong, M., Vichaiwong, K., Toskulkao, C., Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism 58 (2009), 38–47.
27. [27] Buñang, R.D., Validation in awake rats of a tail-cuff method for measuring systolic pressure. J. Appl. Physiol. 34:2 (1973), 279–282.
28. [28] Botelho, L.M.O., Block, C.H., Khosla, M.C., Santos, R.A.S., Plasma angiotensin-(1-7) immunoreactivity is increased by salt load, water deprivation and hemorrhage. Peptides 15 (1994), 723–729.
29. [29] Pereira, R.M., Santos, R.A.S., Teixeira, M.M., et al. The renin-angiotensin system in a rat model of hepatic fibrosis: evidence for a protective role of angiotensin-(1-7). J. Hepatol. 46 (2007), 674–681.
30. [30] Nabulsi, A.A., Folsom, A.R., White, A., Patsch, W., Heiss, G., Wu, K.K., Szklo, M., Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women: the Atherosclerosis Risk in Communities Study. N. Engl. J. Med. 328 (1993), 1069–1075.
31. [31] Haarbo, J., Marslew, U., Gotfredsen, A., Christiansen, C., Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 40 (1991), 1323–1326.
32. [32] Endlich, P.W., Claudio, E.R.G., Gonçalves, W.L.S., Gouvêa, S.A., Moyses, M.R., Abreu, G.R., Swimming training prevents fat deposition and decreases angiotensin II-induced coronary vasoconstriction in ovariectomized rats. Peptides 47 (2013), 29–35.
33. [33] Varbiro, S., Nadasy, G.L., Monos, E., Vajo, Z., Acs, N., Miklos, Z., Tokes, A.M., Szekacs, B., Effect of ovariectomy and hormone replacement therapy on small artery biomechanics in angiotensin-induced hypertension in rats. J. Hypertens. 18 (2000), 1587–1595.
34. [34] Coimbra, R., Sanchez, L.S., Potenza, J.M., Rossoni, L.V., Amaral, S.L., Michelini, L.C., Is gender crucial for cardiovascular adjustments induced by exercise training in female hypertensive rats. Hypertension 52 (2008), 514–521.
35. [35] Endlich, P.W., Firmes, L., Gouvea, S.A., Moyses, M.R., Bissoli, N.S., Reis, A.M., Abreu, G.R., Involvement of the atrial natriuretic peptide in the reduction of arterial pressure induced by swimming but not by running training in hypertensive rats. Peptides 32:8 (2011), 1706–1712.
36. [36] Sampson, A.K., Moritz, K.M., Jones, E.S., Flower, R.L., Widdop, R.E., Denton, K.M., Enhanced Angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attribute to chronic low-dose angiotensin II in female rats. Hypertension 52 (2008), 666–671.
37. [37] Brosnihan, K.B., Li, P., Ganten, D., Ferrario, C.M., Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS. Am. J. Physiol. 273 (1997), R1908–R1915.
38. 1A receptor activation. Br. J. Pharmacol. 148 (2006), 452–458.
39. [39] Tsutsumi, Y., Matsubara, H., Masaki, H., et al. Angiotensin II type 2 receptor overexpression activates the vascular kinins system and causes vasorelaxation. J. Clin. Invest. 104:7 (1999), 925–935.
40. [40] Batenburg, W.W., Tom, B., Schuijt, M.P., Danser, A.H., Angiotensin II type 2 receptor-mediated vasorelaxation Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). Vascul. Pharmacol. 42:3 (2005), 109–118.
41. [41] Izawa, T., Morikawa, M., Inoue, M., Mizuta, T., Yamashita, H., Ohno, H., Komabayashi, T., Acute or chronic exercise alters angiotensin II-induced contraction of rat aorta. Jpn. J. Physiol. 45 (1995), 1093–1100.
42. [42] Silva, D.M.R., Gomes-Filho, A., Olivon, V.C., Santos, T.M.S., Becker, L.K., Santos, R.S., Lemos, V.S., Swimming training improves the vasodilator effect of angiotensin-(1-7) in the aorta of spontaneously hypertensive rats. J. Appl. Physiol. 111 (2011), 1272–1277.
43. [43] Filho, A.G., Ferreira, A.J., Santos, S.H., et al. Selective increase of angiotensin (1-7) and its receptor in hearts of spontaneously hypertensive rats subjected to physical training. Exp. Physiol. 93:5 (2008), 589–598.
44. [44] Walters, P.E., Gaspari, T.A., Widdop, R.E., Angiotensin-(1-7) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 45 (2005), 960–966.
45. [45] Santos, R.A.S., Ferreira, A.J., Verano-Braga, T., Bader, M., Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 216:2 (2013), R1–17.
46. [46] Siragy, H.M., Carey, R.M., The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J. Clin. Invest. 100 (1997), 264–269.
47. [47] Sampaio, W.O., Souza dos Santos, R.A., Faria-Silva, R., da Mata Machado, L.T., Schiffrin, E.L., Touyz, R.M., Angiotensin-(1-7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49 (2007), 185–192.
48. [48] Souza, A.M., Lopes, A.G., Pizzino, C.P., et al. Angiotensin II and angiotensin-(1–7) inhibit the inner cortex Na+- ATPase activity through AT2 receptor. Regul. Pept. 120 (2004), 167–175.
49. [49] Heitsch, H., Brovkovych, S., Malinski, T., Wiemer, G., Angiotensin-(1–7)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 37 (2001), 72–76.
50. [50] Silva, D.M., Vianna, H.R., Cortes, S.F., Campagnole-Santos, M.J., Santos, R.A., Lemos, V.S., Evidence for a new angiotensin-(1-7) receptor subtype in the aorta of Sprague-Dawley rats. Peptides 28:3 (2007), 702–707.